Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
PF00299804, an Irreversible Pan-ERBB Inhibitor, Is Effect... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
PF00299804, an Irreversible Pan-ERBB Inhibitor, Is Effective in Lung Cancer Models withEGFRandERBB2Mutations that Are Resistant to Gefitinib
0
Authors
Jeffrey Engelman
19 more
Jeffrey Engelman
•
James Nelson
17 more
•
Pasi Jänne
Published
December 15, 2007
Paper
Conversation
0
Reviews
0
Bounties
0
Loading PDF viewer…
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Cancer Research
Topics
Biology
Cancer Oncology
Medicine
Internal Medicine
Pulmonary And Respiratory Medicine
Show all topics
DOI
10.1158/0008-5472.can-07-1885
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Cancer Research
Topics
Biology
Cancer Oncology
Medicine
Internal Medicine
Pulmonary And Respiratory Medicine
Show all topics
DOI
10.1158/0008-5472.can-07-1885
Other Formats
PDF
